OTC · Financial Statements

Knight Therapeutics Inc. (KHTRF) Financial Statements

$6.85 OTC: KHTRF Market Cap $672.33M

Knight Therapeutics Inc. most recently reported annual revenue of $450.0M, net profit of $-5.0M, revenue has compounded at 17.6% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$243.0M$294.0M$328.0M$371.0M$450.0M
Operating Profit$-5.0M$-2.0M$-3.0M$7.0M$-2.0M
Net Profit$16.0M$-30.0M$-17.0M$4.0M$-5.0M
EPS$0.13$-0.26$-0.16$0.04$-0.05
Op Margin-2.2%-0.8%-0.9%2.0%-0.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$992.0M$1.1B$945.0M$964.0M$1.0B
Total Liabilities$150.0M$229.0M$199.0M$169.0M$279.0M
Cash$86.0M$72.0M$59.0M$80.0M$76.0M
Borrowings$41.0M$78.0M$69.0M$49.0M$78.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$45.0M$40.0M$36.0M$36.0M$70.0M
Investing Cash Flow$-329.0M$-89.0M$19.0M$-15.0M$-86.0M
Financing Cash Flow$-64.0M$-34.0M$-63.0M$-15.0M$-11.0M
Net Cash Flow$-144.0M$-14.0M$-13.0M$21.0M$0
Free Cash Flow$-180.0M$15.0M$26.0M$5.0M$68.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA9.68
FCF Yield11.58%
Quick Ratio1.49
Interest Coverage2.39
Return 1Y46.95%
Return 3Y87.62%
Return 5Y63.91%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
KHTRF Overview KHTRF Dividend Run Stock Screener